Recent studies point out disagreements in approaches to treating high blood pressure.

Painkillers are an essential component for treating millions of patients, but growing concern about addiction and abuse has prompted a group of U.S. state health officials, public advocates and doctors to call for change.

GE Ventures and the Mayo Clinic have launched Vitruvian Networks, an independent platform company committed to accelerating access to cell and gene therapies through advanced, cloud-ready software systems and manufacturing services.

Eric Dishman, vice president and Intel fellow of Intel's Health and Life Sciences Group, has been tapped by the National Institutes of Health to become director of the Precision Medicine Initiative Cohort Program. 

A recent study in the American Journal of Managed Care found evidence that reductions in specialty drug utilization were associated with higher cost sharing, with the effects varying by the type of disease and outcome of the drug in use.

Findings from the World Health Organization suggest every U.S. dollar invested in mental health treatment can quadruple returns in work productivity. However, most countries are investing far below what is needed for those suffering from common mental disorders.

Venture capital funding, including private equity and corporate venture capital, in the health IT sector increased 27 percent quarter over quarter, coming in at $1.4 billion in 146 deals compared to $1.1 billion in 145 deals in Q4 2015, according to a Mercom Capital Group report. 

OSF HealthCare has launched OSF Ventures designed to strategically invest in new technology and devices that can transform and improve healthcare.